SOURCES SOUGHT
66 -- SOURCES SOUGHT NOTICE FOR MOLECULAR DETECTION SYSTEM
- Notice Date
- 5/20/2013
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA1116504
- Archive Date
- 6/8/2013
- Point of Contact
- Howard S. Yablon, Phone: 3108276766
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a SOURCES SOUGHT NOTICE to determine the availability and capability of qualified small businesses (including certified 8(a), Small Disadvantaged, HUBZone firms; veteran and service-disabled veteran-owned small businesses, and women-owned small businesses) to provide a molecular detection system that is capable of bioluminescence-based detection of DNA amplification products obtained through isothermal DNA amplification techniques, including loop-mediated isothermal amplification (LAMP). During LAMP reaction, large quantities of byproducts called magnesium pyrophosphate are generated. Pyrophosphate ions react with enzymes and substrates supplied in the reaction tubes and generate bioluminescence signals, which need to be monitored in real time. The system needs to contain a reaction block with both temperature control and bioluminescence monitoring capabilities. The Contractor must satisfy the following requirements, provide a detailed description of your company's (including its teammates, if applicable) experience and demonstrated abilities to deliver each and every one separately of the minimum Salient Characteristics for the System, the Additional Supplies Needed and the Warranty and Technical Support as stated below: Minimum Salient Characteristics for the System: 1. Must be capable of both temperature control and bioluminescence monitoring. 2. Must be capable of bioluminescence-based detection of DNA amplification products obtained through isothermal DNA amplification techniques, including loop-mediated isothermal amplification (LAMP). 3. Must contain a reaction block that accommodates 16-96 sample tubes (capacity 200 µl each). 4. Temperature control within the block to be with ± 0.5oC accuracy. 5. A bioluminescence monitoring system that monitors light signals every minute. 6. External communication through USB. 7. A user-friendly software that displays reaction progress and generates final reports which includes information on completed runs, samples, assay kits, user logs, temperature logs, run layouts and run reports. 8. Heater needs to be removable for easy cleaning 9. Software must allow for multi-tasking; must be able to use software while runs are in progress. 10. Unit must allow for user to test 1 and up to 96 samples per run. 11. Instrument needs to come with a pluggable heater, all required software, power cord, and any accessories necessary for installation and to get started. (Note: Purchase of computer is not needed under this order.) Additional Supplies: With the purchase of the system, the FDA requires the following supplies (or equivalents) to be compatible with the system proposed: Line Item Description 3M Part Number Qty 1 Salmonella Assay Kit (96 tests/kit) MDAS96NA 2 2 E. Coli Assay Kit (96 tests/kit) MDAEC96NA 1 3 Listeria Assay Kit (96 tests/kit) MDAL96NA 1 4 Matrix Control Assay Kit (96 tests/kit) MDMC96NA 2 5 500g Pepton Water Dehydrated culture media BPW500 1 6 500g Bottle of Listeria enrichments, modified Listeria recovery broth MLRB500 1 7 1g Bottle of Listeria enrichments, modified Listeria broth supplement MLRBSUP001 1 Warranty and technical support Instrument system must include a warranty/annual service and support for 1 year. Support must be available via telephone during normal business hours (Monday-Friday, 8:00am-5:30pm). A maintenance agreement past the initial year service/support is not required. The anticipated period of performance is from April 20, 2013 to July 20, 2013.. The NAICS Code is 334516 (Analytical Laboratory Instrument Manufacturing) with a standard size of 500 employees. Interested small business offerors are encouraged to respond to this notice. However, be advised that generic capability statements are not sufficient for effective evaluation of respondents' capacity and capability to perform the specific work as required. Response must directly demonstrate the company's capability, experience, and/or ability to effectively meet each of the scientific instrument's salient characteristics, the additional supplies needed and the warranty and technical support described above in sufficient level of detail. Failure to definitively address each of these factors will result in a finding that respondent lacks capability to perform the work. Responses to this notice (capability statements) shall be limited to five (5) pages, and must include: 1. Company name, mailing address, e-mail address, telephone and FAX numbers, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives. 2.Name, title, telephone number, and e-mail addresses of individuals who can verify the demonstrated capabilities identified in the responses. 3.Business size for NAICS 334515 ( number of employees, 500) and status, if qualified as a 8(a) firm (must be certified by SBA), Small Disadvantaged Business (must be certified by SBA), Woman-Owned Small Business, HUBZone firm (must be certified by SBA), and/or Service-Disabled Veteran-Owned Small Business (must be listed in the VetBiz Vendor Information Pages). 4.DUNS number, CAGE Code, Tax Identification Number, and company structure (Corporation, LLC, partnership, joint venture, etc.). Companies also must be registered in the SAM (System for Award Management, www.sam.gov) to be considered as potential sources. Please submit copies of any documentation such as letters or certificates to indicate the firm's status (see item #3, above). To the maximum extent possible, please submit non-proprietary information. Any proprietary information submitted should be identified as such and will be properly protected from disclosure. This notice is for planning purposes only, and does not constitute an Invitation for Bids, a Request for Proposals, a Solicitation, and a Request for Quotes, or an indication the Government will contract for the items contained in this announcement. This request is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this request. The Government will not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this announcement. Responses to this announcement will not be returned, nor are there any ensuing discussions or debriefings of any responses. However, information obtained as a result of this announcement may be reflected in the subsequent solicitation, and FDA, OAGS may contact one or more respondents for clarifications and to enhance the Government's understanding. This announcement is Government market research, and may result in revisions in both its requirements and its acquisition strategy based on industry responses. RESPONDENTS MUST SUBMIT CAPABILITY STATEMENT VIA E-MAIL to Howard S. Yablon at howard.yablon@fda.hhs.gov no later than May 24, 2013 4:00 PM ET for consideration.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA1116504/listing.html)
- Place of Performance
- Address: 8401 Muirkirk Rd, Laurel, Maryland, 20708, United States
- Zip Code: 20708
- Zip Code: 20708
- Record
- SN03066877-W 20130522/130520234756-36e769106121f9e1d96240891c1c6740 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |